The Most Research-Backed CannabisIntervention Available

Built by a team that has published hundreds of peer-reviewed studies with tens of thousands of citations across addiction science, digital intervention, and cannabis research, and funded by the National Institutes of Health.

Reasons for Taking a Break
Days Using Before Break
Clear30 Research Statistics

Research backed by universities

We evaluate engagement, outcomes, and real-world use of digital cannabis support tools.

Engagement

how often users show up and stick with it

🏆

Outcomes

Changes in behavior or wellbeing

🌐

Real-world use

How people apply it outside the app

Research partners

Harvard University
National Institutes of Health
University of Michigan
University of Michigan DC³ collaboration

Clear30 collaborates with the University of Michigan's Digital Cannabis Clinical Care (DC³) initiative to evaluate and scale evidence-based cannabis support for students and young adults.

Harvard-affiliated research

Our research partnerships with Harvard-affiliated teams help assess Clear30's effectiveness as a scalable intervention for cannabis use among college students and young adults.

Funded by the National
Institutes of Health

Clear30 was built with a competitive NIH/NIDA SBIR grant. We've completed Phase 1, which included building the core app and developing an adolescent version. The same research team continues to guide the product today.

Scientific and Clinical Advisors

  • Clear30's advisory leadership provides expert guidance across addiction science, clinical care, public health policy, and behavior change.
  • These advisors help ensure Clear30 is developed and evaluated in ways that align with established research, real-world clinical practice, and the needs of institutions supporting student and young adult well-being.
  • Their involvement strengthens Clear30 as a responsible, evidence-informed partner for universities and health organizations.
Contact our team
Dr. Fred Muench - Clear30 Scientific and Clinical Advisors

Advisory Leadership

  • Alan Budney

    Alan Budney, PhD

    Professor at Dartmouth College and one of the world's leading researchers in cannabis use disorder treatment, behavioral therapies, and treatment outcomes.

  • A. Thomas McLellan

    A. Thomas McLellan, PhD

    Creator of the Addiction Severity Index and former U.S. Deputy Director of National Drug Control Policy, with decades of experience shaping addiction treatment standards and national policy.

  • Stephen D'Antonio

    Stephen D'Antonio

    Former Executive Vice President at Shatterproof, trained in evidence-based family treatment approaches and large-scale behavioral health program implementation.

  • Kamala Génecé

    Kamala Génecé

    Chief Clinical Officer at Behavioral Health Group, focused on clinical implementation of evidence-based behavioral health supports across care settings.

  • Lauren Johnson

    Lauren Johnson

    Marketing Director at Fors Marsh, specializing in public health communications, behavior change messaging, and large-scale health campaigns.

  • Marcia Lee Taylor

    Marcia Lee Taylor

    Founder of MLT Strategies to reduce opioid overdoses, former EVP Head of Policy at Partnership to End Addiction.

Peer-reviewed research and publications

Clear30's design and approach are informed by a broad body of peer-reviewed research contributed by its leadership and advisors.

These publications span digital mental health, addiction treatment, behavior change, and cannabis use, and reflect decades of academic and clinical work that shape how Clear30 is built and evaluated.

Peer Review: A Critical Inquiry by David Shatz

Hundreds of Publications. Tens of Thousands of Citations.

Fred Muench

Fred Muench, PhD

Alan Budney

Alan Budney, PhD